Precision medicine
Canvas Dx is indicated as an aid in the diagnosis of ASD in patients between the ages 18 months and 5 years old who are at risk of developmental delay.
2bPrecise CEO Assaf Halevy discusses how genomic information can be injected into the workflow to manage the treatment of the patient.
The company's technology looks to reduce the burden on pathologists reviewing digital slides, while also serving as a safety net to reduce errors.